Abstract:Background: Carotid artery stenosis (50-99% extracranial internal carotid artery narrowing) is a risk factor for ischemic stroke. Yet, no population-based studies have directly assessed the benefits and harms of screening for asymptomatic carotid artery stenosis (ACAS). Given the variability in ACAS prevalence and stroke risk according to clinical factors, we sought to evaluate the cost-effectiveness of ACAS screening by cardiovascular risk-stratified subgroups. Methods: We developed a microsimulation model of ACAS and stroke to project the lifetime costs and quality-adjusted life-years (QALYs) associated with ACAS screening, stratified by individuals' 10-year atherosclerotic cardiovascular disease (ASCVD) risk predicted from the pooled cohort equations. The model cohort was representative of US adults aged 50-80 years without history of stroke, constructed using sampling with replacement from the National Health and Nutrition Examination Survey. We used the Cardiovascular Health Study to estimate the severity of ACAS based on individual characteristics (e.g., age, sex, smoking status, blood pressure, and cholesterol). Stroke risks were functions of these characteristics and ACAS severity. In the model, individuals testing positive with Duplex ultrasound (>70% stenosis) and a confirmatory diagnostic test undergo revascularization, which reduces the risk of stroke but also introduces complication risks. Diagnostic performance parameters, revascularization benefits and risks, event rates associated with stroke, utility weights, and costs were estimated from published sources. Cost-effectiveness was assessed from the health care sector perspective using a $100,000/QALY threshold. Results: We found that screening individuals with a 10-year ASCVD risk greater than 25% was the most cost-effective strategy, with an incremental cost-effectiveness ratio of $78,000/QALY. This strategy would make approximately 23% of the US adult population aged 50-80 years eligible for screening, averting an estimated 53,709 strokes. Results were sensitive to variations in key parameters, including the efficacy and complication risk of revascularization. Conclusions: Although the US Preventive Services Task Force recommends against ACAS screening in the general population, a one-time screening may be cost-effective for adults with ASCVD risk >25%. Nonetheless, the cost-effectiveness of such screening is contingent on updated findings from ongoing research like the CREST-2 trial, which could reshape the understanding of revascularization's efficacy in contemporary medical practice.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the cost - effectiveness of a one - time screening strategy for asymptomatic carotid artery stenosis (ACAS), especially the cost - effectiveness of screening based on different thresholds of atherosclerotic cardiovascular disease (ASCVD) risk. Specifically, the study aims to answer the following key questions: 1. **Cost - effectiveness of screening strategies**: Which screening strategy based on 10 - year ASCVD risk is the most cost - effective? 2. **Selection of screening population**: Which populations should be screened for ACAS to maximize the effect of stroke prevention? 3. **Sensitivity analysis of screening effectiveness**: How is the effectiveness of the screening strategy affected by the effectiveness and complication risks of revascularization procedures? ### Research background - **Carotid artery stenosis and stroke**: Carotid artery stenosis is an important risk factor for ischemic stroke, but there is currently a lack of extensive screening studies for asymptomatic carotid artery stenosis. - **Revascularization procedures**: For patients with severe carotid artery stenosis, revascularization procedures (such as carotid endarterectomy or carotid artery stenting) can reduce the risk of stroke, but may also bring complications. - **Existing guidelines**: The US Preventive Services Task Force (USPSTF) and other professional societies currently do not recommend universal screening for ACAS, but suggest considering screening for individuals with multiple stroke risk factors. ### Research methods - **Model construction**: The researchers developed a life - cycle microsimulation model to simulate the occurrence process of ACAS and stroke. - **Cohort selection**: The cohort assumed by the model represents American adults aged 50 - 80 without a history of stroke. - **Risk prediction**: The Pooled Cohort Equations (PCEs) of the American Heart Association were used to predict the 10 - year ASCVD risk of each individual. - **Screening strategies**: Multiple screening strategies based on 10 - year ASCVD risk thresholds were evaluated, including > 35%, > 30%, > 25%, > 20%, > 15%, > 10% and > 5%. ### Main results - **Optimal strategy**: Under the cost - effectiveness threshold of $100,000/QALY, screening individuals with a 10 - year ASCVD risk greater than 30% is the most cost - effective strategy, with an incremental cost - effectiveness ratio (ICER) of $89,000/QALY. - **Screening coverage**: This strategy makes approximately 11.9% of the population eligible and is expected to prevent 24,084 strokes. - **Sensitivity analysis**: The effectiveness of the screening strategy is very sensitive to the effectiveness and complication risks of revascularization procedures. If these parameters change, the optimal screening threshold may be different. ### Conclusions - **Main findings**: One - time ACAS screening may be cost - effective only in adults with high ASCVD risk. - **Future directions**: With the release of the results of the CREST - 2 trial, these analyses can provide a framework for future screening recommendations, especially in evaluating the relative benefits of revascularization procedures and intensive medical treatment. Through these studies, the authors hope to provide a scientific basis for clinical decision - making, optimize ACAS screening strategies, and thus prevent strokes more effectively.

Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular Risk

Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force

Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease

Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of …

Usefulness of Carotid Ultrasound Screening in Primary Cardiovascular Prevention: A Systematic Review

Cost-Effectiveness Analysis of Atrial Fibrillation Screening for Stroke Prevention in China: A Markov Model

Carotid Atherosclerosis Detected by Ultrasonography: A National Cross‐Sectional Study

Abstract 138: Cost-Effectiveness of Insertable Cardiac Monitors to Identify Atrial Fibrillation After Stroke Attributed to Large-Artery or Small-Vessel Disease

Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins

Carotid artery stenting versus carotid endarterectomy for symptomatic or asymptomatic extracranial carotid stenosis: A national cohort study

Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis

Utility of Routine Carotid Duplex Screening in Patients Who Have Claudication.

Abstract WMP46: Frequency of High-Risk Features and Stroke Risk in Asymptomatic Carotid Atherosclerosis: Systematic Review and Meta-Analysis

A comparative effectiveness study of carotid intervention for long-term stroke prevention in patients with severe asymptomatic stenosis from a large integrated health system

Detection of Asymptomatic Carotid Artery Stenosis in High-Risk Individuals of Stroke Using a Machine-Learning Algorithm.

Development and pilot feasibility study of a health information technology tool to calculate mortality risk for patients with asymptomatic carotid stenosis: the Carotid Risk Assessment Tool (CARAT)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events

Ideal Cardiovascular Health Metrics on the Prevalence of Asymptomatic Intracranial Artery Stenosis: A Cross-Sectional Study

Role of Carotid Artery Stenting in Prevention of Stroke for Asymptomatic Carotid Stenosis: Bayesian Cross-Design and Network Meta-Analyses

[Effectiveness of Different Screening Strategies for Cardiovascular Diseases Prevention in a Community-Based Chinese Population: A Decision-Analytic Markov Model].

Implications of coronary artery calcium testing for treatment decisions among statin candidates according to the ACC/AHA cholesterol management guidelines: a cost-effectiveness …